brevifoliol

structure in first source

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

1.	Prostatic Neoplasms (Prostate Cancer) 01/01/2020 - "Brevifoliol ester induces apoptosis in prostate cancer cells by activation of caspase pathway."
2.	Neoplasms (Cancer) 07/01/2008 - "Brevifoliol and its synthesized analogues were tested for their cytotoxic activities against four different human cancer cell lines, oral (KB), breast (MCF-7), colon (CaCO2) and liver (HepG-2) as determined by MTT assay. "
3.	Lung Neoplasms (Lung Cancer) 05/01/2008 - "Twenty-one derivatives of taxchinin A (1) and brevifoliol (2) were synthesized and evaluated for cytotoxicity against human non-small lung cancer (A549) cell line. "
4.	Liver Neoplasms (Liver Cancer) 07/01/2008 - "Out of the seven analogues synthesized, C-13 oxidized brevifoliol-5-[N-tert-butoxycarbonyl amino-(2'R,3'S)-3'-phenyl isoserine] analogue was interesting as it exhibited selective and potent cytotoxicity against liver cancer cell line predominantly."